BioWorld

May 3, 2007

View Archived Issues

Array Raises $91M Publicly For Cancer, Inflammation Programs

Array BioPharma Inc. raised $91 million in a public offering of stock, money that will be used to fund development of its broad, early stage pipeline of small-molecule drug candidates for cancer and inflammatory diseases. (BioWorld Today) Read More

Varying FOB Proposals Seem To Signal Compromise In The Works

Read More

Specific Starvation Gene Joins Sirtuins As Longevity Target

Read More

NeurogesX Lowers Share Price Again, Brings In $44M In IPO

Read More

AVI, Ercole Join Technologies To Tackle DMD, Thalassemia

Read More

Immunomedics Raises $24M For Anticancer Antibodies

Read More

Other News To Note

Read More

Clinic Roundup

Read More